We are live on ! Find out more
PCM

Puissance Capital Management Portfolio holdings

AUM $17.3M
1-Year Est. Return 149.36%
This Fund
S&P 500
This Quarter Est. Return
-25.39%
1 Year Est. Return
+149.36%
3 Year Est. Return
+115.5%
5 Year Est. Return
10 Year Est. Return
AUM
$17.3M
AUM Growth
-$6.08M
Cap. Flow
+$421K
Cap. Flow %
2.43%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
KDMN
Kadmon Holdings, Inc.
KDMN
+$421K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Healthcare 11.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLPH
1
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$11.7M 67.74%
1,153,846
CHRN
2
ChronoScale Holdings
CHRN
$2.69B
$3.68M 21.21%
51,627
SCYX icon
3
SCYNEXIS
SCYX
$37.4M
$1.37M 7.91%
38,893
KDMN
4
DELISTED
Kadmon Holdings, Inc.
KDMN
$393K 2.27%
+100,184
New +$421K
CRVS icon
5
Corvus Pharmaceuticals
CRVS
$1.1B
$152K 0.88%
38,010

Similar funds

Puissance Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Puissance Capital Management held 5 positions worth $17.3M, down 26% from $23.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Puissance Capital Management's Q3 2020 filing shows 1 new position. Its largest new stake was Kadmon Holdings, Inc.: 100,184 shares worth $393K.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 28% a quarter earlier, followed by Healthcare.

  • Puissance Capital Management's largest Q3 2020 buy was Kadmon Holdings, Inc.: 100,184 shares worth $393K.
  • Puissance Capital Management's ten largest holdings make up 100% of its $17.3M portfolio in Q3 2020.
  • Puissance Capital Management opened 1 new position and closed 0 in Q3 2020.
  • Puissance Capital Management's portfolio value fell 26% quarter-over-quarter to $17.3M.

Based on Puissance Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.